02 March 2021 p 01 Patientcentric innovation Mette

02 March 2021 p. 01 Patient-centric innovation Mette Vestergaard Senior Vice President Global People and Communications LEO Pharma A/S

Our mission

02 March 2021 3

Our innovation eco-system 02 March 2021 p. 04

p. 05 The simple message of Open Innovation

How to make it happen 02 March 2021 p. 06 Barriers in the traditional R&D model The traditional ‘barrier’ between external science and the R&D process. The ‘barrier’ moved a step to the right, exposing part of the research platform for external parties who are invited to use these R&D capabilities.

¨ First of its kind study that measures the happiness gap between people living with a skin condition and the average population as benchmarked by the UN Happiness Report. ● The psoriasis happiness gap is 12% in Denmark, 20% in the US and 24% in UK ● We will continue to document the inequality in wellbeing and work towards improving happiness for all people living with a chronic condition

Pioneering Psoriasis Tracking 1 2 3 Track your psoriasis Understand what’s going on Take control We aim to build the largest database of validated psoriasis photos Through automated image analysis, users gain more insight into the development of their psoriasis, motivating adherence and lifestyle experimentation.

02 March 2021 p. 010 Our approach to the SDGs

How we will work with the SDGs 02 March 2021 p. 011 The SDGs have been part of our work with building the new CSR Commitment for 2018 -2020. We have assessed our impact on each of the 17 SDGs and their respective targets. CSR Commitment 2018 -2020

CSR Commitment process Research 48 topics identified, incl. links to the SDGs Prioritisati on of topics Reduction to topics 16 Materiality assessment 02 March 2021 p. 012 CSR Commitment 2018 -2020 development CSR Commitment 2018 -2020 implementati on CSR Commitment 2018 -2020

02 March 2021 p. 013 Questions?